We use cookies on this site. Cookies are small text files that are stored on your computer by websites. Cookies are widely used and help to optimize the pages that you view. By using this site, you agree to their use. more


The moment radiotherapy can be ideally tailored to the needs of your patient.

This is the moment we work for.



5-Year Results


Teaser get touch


The right contact person for your request

Locations & contact numbers
Contact form
Service contact

Looking for a certain product?

Use our productfinder!

Intrabeam Services

Interactive worldmap

Displaying all installed ZEISS INTRABEAM Systems worldwide



TARGIT - TARGeted Intraoperative Radiotherapy with INTRABEAM

The trend in oncological therapy is moving towards the targeted, risk-adapted and interdisciplinary treatment of tumors. INTRABEAM®, the innovative radiotherapy system from Carl Zeiss, is an ideal system for these requirements.

  • Localised tumor control – targeted effectiveness
  • Localised irradiation with a high radio-biological effectiveness
  • Practical mobility and fast workflow integration
  • Versatility of the clinical application
  • High quality of life outcomes and treatment comfort for patients

Targeted Radiotherapy for a Wide Range of Applications


4 steps web

Breast Cancer Treatment with Targeted Intraoperative Radiotherapy

Targeted intraoperative radiation with INTRABEAM is a risk-adapted individualised therapy. The 30-minute irradiation procedure is performed during the operation immediately after the tumor is excised. During this procedure, the isotropic dose distribution is applied directly into the tumor cavity using a spherical applicator in a way that ensures direct contact with the target tissue. Radiation is applied precisely to the area with the highest risk of tumor recurrence. The surrounding healthy tissue is spared.

4 steps web a

A: Step 1 - The position of the tumor is determined.

4 steps web b

B: Step 2 - The tumor is surgically removed.

4 steps web c

C: Step 3 - The INTRABEAM applicator tip is positioned on the tumor cavity in the breast.

4 steps web d

D: Step 4 - The radiation is applied for about 30 minutes. The applicator is removed and the incision closed.

Intraoperative radiotherapy (IORT) with INTRABEAM can be adapted to the needs of the patient. Risk-adapted alternatives following breast-conserving surgery (BCS) of the mammary carcinoma:

TARGIT single dose radiotherapy
TARGIT Therapy as a Boost
TARGIT-A Trial: 5-Year Results



Show moreShow more

More Applications


Radiotherapy for Spinal Metastases with INTRABEAM

Treatment of spinal metastases with Kypho-IORT

For many cancer patients who develop spinal metastases in the natural course of their disease, percutaneous kyphoplasty and vertebroplasty are a valuable treatment option. By using intraoperative radiotherapy with INTRABEAM during kyphoplasty or vertrebroplasty, the metastasis can be sterilized and if necessary vertebra simultaneously stabilized, a solution that results in reduction of patient’s discomfort. It also restores mobility, significantly enhancing the patient’s quality of life. The first clinical trial experience of this approach has yielded very promising results.3


Kypho 6 Schritte Web

Step 1:
Vertebral body containing a bone metastasis


Kypho 6 Schritte Web

Step 4:
A balloon is inserted in the vertebral body with painfull lesions

Kypho 6 Schritte Web

Step 2:
A minimal invasive access is created

Kypho 6 Schritte Web

Step 5:
The balloon is carefuly inflated, returning the vertebral body to its normal position

Kypho 6 Schritte Web

Step 3:
Radiation (< 5 min) of the bone metastasis at its precise location

Kypho 6 Schritte Web

Step 6:
The cavity created by the balloon is filled with bone cement for stabilization

Show moreShow more

Radiotherapy for Gastrointestinal Cancer with INTRABEAM

Gastrointestinal Cancer Treatment

In cancer surgery, the primary goal is to completely excise the tumor. However, incomplete resection is sometimes the outcome. INTRABEAM can be used to improve local control of colorectal tumors. The value of INTRABEAM has also been demonstrated in the setting of laparoscopic hemicolectomy in patients with colon cancer and gastrectomy in patients with gastric cancer.4

Radiotherapy for Endometrial Cancer with INTRABEAM

Endometrial Cancer Treatment

In endometrial cancer – the most common malignancy of the female reproductive system – the use of INTRABEAM is also feasible and has some potential advantages compared to brachytherapy, which requires complex radiation protection. By comparison, INTRABEAM can be implemented without high investment costs.

First clinical trial evidence has proved that it is possible to create a homogeneous cylindrical dose distribution similar to 192Ir HDR afterloading, suggesting that INTRABEAM can be used effectively in this common female cancer.

Radiotherapy for Skin Cancer with INTRABEAM

Skin Cancer Treatment

The versatility of INTRABEAM is also displayed in the treatment of skin cancer. Particularly in the treatment of non-melanoma skin cancer, irradiation is an important therapy option. In a prospective study, it was shown that intraoperative radiotherapy with INTRABEAM was as effective in the management of non-melanoma skin cancer as conventional radiotherapy techniques. The well-known advantages of INTRABEAM – targeted radiation delivery, low shielding requirements, and cost effectiveness – also hold true for the treatment of skin cancer.5,6

Radiotherapy for Oral Cancer with INTRABEAM

Oral Cancer Treatment

Delivering a boost radiation intraoperatively with INTRABEAM has potential advantages in the treatment of oral cancers. After resection, the margins of the tumor can be sterilized immediately, which may have a positive impact on local recurrence rate. Additionally, the numerous sensitive structures in this anatomical region can be spared due to the steep fall-off of the low-energy radiation emitted by INTRABEAM. A geographical miss is unlikely since the applicator can be positioned directly in the tumor bed. First study data have convincingly demonstrated the value of this concept.7

1 Wenz F, Kraus-Tiefenbacher U: Intraoperative Radiotherapy for Breast Cancer, Uni-Med, 2011; 51

2 Vaidya JS, Tobias JS, Baum M, et al.: TARGeted Intraoperative radioTherapy (TARGIT): An Innovative Approach to Partial-Breast Irradition, Semin Radiat Oncol, 2005, 84-91

3 Wenz F, Schneider F, Neumaier C et al. Kypho-IORT – a novel approach of intraoperative radiotherapy during kyphoplasty for vertebral metastases. Radiat Oncol 2010; 5: 11

4 Lyadov KV, Yu A, Sinyakin S, Improvement of Curativity of Video-Assisted Surgery for Colorectal Cancer Due to Intra-Operative Contact Radiotherapy Using the INTRABEAM System. Poster abstract presented at the ISIORT annual meeting 2008, Madrid, Spain

5 Bodner WR, Hilaris BS, Alagheband M et al. Use of low-energy X-rays in the treatment of superficial nonmelanomatous skin cancers. Cancer Invest 2003; 21(3): 355-62

6 Locke J, Karimpour S, Young G et al. Radiotherapy for epithelial skin cancer. Int J Radiat Oncol Biol Phys 2001; 51(3): 748-5520 Bodner WR, Hilaris BS, Alagheband M et al. Use of low-energy X-rays in the treatment of superficial nonmelanomatous skin cancers. Cancer Invest 2003; 21(3): 355-62

7 Rutkowski T, Wygoda A, Hutnik M et al. Intraoperative radiotherapy (IORT) with lowenergy photons as a boost in patients with earlystage oral cancer with the indications for postoperative radiotherapy: treatment feasibility and preliminary results. Strahlenther Onkol 2010; 86(9): 496–501

INTRABEAM Product information
INTRABEAM, the innovative radiotherapy system from Carl Zeiss, is an ideal system for these requirements.